Registration
 
All news
Top Stories
Editors' Picks
Stocks
Crypto
Economics
Currencies
Commodities
Market Voices
Companies
Anastasiia Chabaniuk
Anastasiia Chabaniuk

Edgewise Therapeutics presents muscular dystrophy research at Vienna conference

Edgewise Therapeutics presents muscular dystrophy research at Vienna conference
@EdgewiseTx: Edgewise in Vienna

Edgewise Therapeutics is showcasing its muscular dystrophy research at the World Muscle Society conference in Vienna.

The company will present scientific poster displays during session 4 on Friday, October 10, from 3:45 to 4:45 pm CET. Attendees are encouraged to visit booth #16 for discussions with the Edgewise team.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

Do politicians make the best stock traders?
  • By Ciaran Ryan
  • 18 hours ago
Do politicians make the best stock traders?
Editors' Picks
Crypto test drive: How automakers are exploring digital assets
  • By Anastasiia Chabaniuk
  • Yesterday
Crypto test drive: How automakers are exploring digital assets
Editors' Picks
Lindsey Graham death: U.S. senator’s crypto legacy
  • By Mikhail Vnuchkov
  • 13.07.2026
Lindsey Graham death: U.S. senator’s crypto legacy
Editors' Picks
All Editors' Top Picks

Latest Edgewise News

Edgewise Therapeutics stock consolidates near key support as bullish momentum persists
  • By Andreas Kristo
  • 03.07.2026
Edgewise Therapeutics stock consolidates near key support as bullish momentum persists
Companies
#Edgewise
Edgewise Therapeutics stock surges 8.94% to $42.30 as company gears up for EAN poster reveal
  • By Andreas Kristo
  • 25.06.2026
Edgewise Therapeutics stock surges 8.94% to $42.30 as company gears up for EAN poster reveal
Companies
#Edgewise
Edgewise Therapeutics stock jumps 5.89 percent as company readies for BIO 2026 event
  • By Emilio Ghigini
  • 24.06.2026
Edgewise Therapeutics stock jumps 5.89 percent as company readies for BIO 2026 event
Companies
#Edgewise
All Edgewise News
  • Ciaran Ryan
  • 18 hours ago
Do politicians make the best stock traders?
  • Anastasiia Chabaniuk
  • Yesterday
Crypto test drive: How automakers are exploring digital assets
  • Mikhail Vnuchkov
  • 13.07.2026
Lindsey Graham death: U.S. senator’s crypto legacy
  • Pavlo Kot
  • 12.07.2026
Tether under pressure: USDT in Europe, audit questions, and the fight for trust
  • Pavlo Kot
  • 11.07.2026
Lean Ethereum: Why Buterin wants to rebuild the network
  • Oleg Tkachenko
  • 46 min ago
Anthony Pompliano: Market opportunity for Silvia is significant among self-directed investors
  • Yaroslav Dmytrenko
  • 46 min ago
Bitcoin declines and diverges from S&P 500 in Q2, Frank Chaparro notes
  • Jose Antonio Gastelum
  • 1 hour ago
Mason Versluis: XRP influencers misleading on SWIFT and DTCC news
  • Mikhail Vnuchkov
  • 1 hour ago
Aswath Damodaran: Ratings agency changes often lag market reality
  • Yaroslav Dmytrenko
  • 1 hour ago
Richard Byworth: BTC yield name debated for increasing BTC per share
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.
Top News
  • Andrey Mastykin
  • 9 hours ago
ECB faces harder rate call as Middle East conflict pushes crude prices higher
ECB faces harder rate call as Middle East conflict pushes crude prices higher
  • Olga Shendetskaya
  • 10 hours ago
ASML rises after raising sales forecast on AI chip demand
ASML rises after raising sales forecast on AI chip demand
  • Parshwa Turakhiya
  • 12 hours ago
BlackRock tops profit estimates as assets climb to $15 trillion
BlackRock tops profit estimates as assets climb to $15 trillion
  • Ivan Andriyenko
  • 13 hours ago
Brent and WTI rise as new U.S. strikes raise supply fears
Brent and WTI rise as new U.S. strikes raise supply fears
  • Hanna Syniavska
  • 15 hours ago
PayPal receives $53 billion takeover offer from Stripe and Advent
PayPal receives $53 billion takeover offer from Stripe and Advent
Live News
  • Mykhailo Ihnatenko
  • Now
Snowflake stock outlook: Is $300 next target?
  • Anton Kharitonov
  • Now
Microsoft stabilizes as AI optimism offsets spending concerns
  • Anton Kharitonov
  • Now
Google consolidates as AI momentum offsets regulatory pressure
  • Mykhailo Ihnatenko
  • Now
Intel shares brace for earnings: Can INTC avoid an IBM-style selloff?
  • Anton Kharitonov
  • Now
Bitcoin rebounds as softer U.S. inflation supports recovery despite geopolitical risks
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org World Association of News Publishers https://gdpr.eu/ GDPR